Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Daegu
Clinical trial register · South Korea

Clinical Trials in Daegu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 26 Daegu 15 Seongnam-si 13 Goyang-si 11 Cheongju-si 8
Narrow the registerReset
Recruitment status
Phase
Site location
Seoul26 Daegu15 Seongnam-si13 Goyang-si11 Cheongju-si8
All 21 locations
Target enrolment
to

Trials with a site in Daegu

15 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
Daiichi Sankyo
Phase 3
710
Daegu, Seoul
2025-09-30
Recruiting
Daiichi Sankyo
Phase 2
130
Busan, Daegu, Goyang-si, Incheon, Jeonju, Seongnam, Seoul, Suwon
2025-07-18
Recruiting
Daiichi Sankyo
Phase 3
510
Daegu, Goyang-si, Hwasun-gun, Incheon, Seongnam-si, Seoul
2025-03-27
Recruiting
Daiichi Sankyo
Phase 3
726
Cheongju-si, Daegu, Goyang-si, Hwasun-gun, Incheon, Jeonju, Seongnam, Seongnam-si
2025-02-27
Active, closed
Daiichi Sankyo
Phase 3
700
Busan, Daegu, Hwasun-gun, Incheon, Jeonju, Seongnam-si, Seoul, Suwon
2024-11-19
Recruiting
Daiichi Sankyo
Phase 3
540
Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon
2024-05-21
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
Daiichi Sankyo
Phase 2
740
Daegu, Gyeonggi-do, Seongnam, Seoul
2024-02-26
Recruiting
Daiichi Sankyo
Phase 3
50
Daegu, Gyeonggi-do, Jongno-gu, Seoul
2024-01-05
Active, closed
Daiichi Sankyo
Phase 3
1,170
Cheongju-si, Daegu, Gangnam-Gu, Goyang-si, Jinju-si Gyeongsangnam-do, Seongnam-si, Seoul
2023-01-11
Active, closed
Daiichi Sankyo
Phase 3
740
Seongnam-si, Jinju, Cheongju-si, Daegu, Goyang-si, Seoul, Songpa-gu
2022-03-04
Active, closed
Daiichi Sankyo
Phase 3
490
Daegu, Hwasun, Seongnam, Seoul
2021-05-21
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Daiichi Sankyo
Phase 2
277
Songpa-gu, Cheongju-si, Daegu, Goyang-si, Seongnam, Seoul
2021-02-02
Active, closed
Daiichi Sankyo
Phase 3
605
Cheongju-si, Daegu, Gyeonggi-do, Seongnam-si, Seoul
2020-12-21
Active, closed
Daiichi Sankyo
Phase 3
1,600
Daegu, Gyeonggi-do, Incheon, Irwon-dong, Seoul, Songpa-gu, Yongsan
2020-12-04
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/daegu

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Daegu that also match the filters currently applied.

How many clinical trials are recruiting in Daegu?

8 of the 15 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Daegu), 15 studies
PhaseStudiesRecruitingShare
Phase 312680%
Phase 23220%

Most active sponsors

Lead sponsors with the most studies (Daegu)
Lead sponsorStudiesRecruiting
Daiichi Sankyo158
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.